Home/Publication/Qiming, B Capital et al to Enhance Cell Therapy Tech
Qiming, B Capital et al to Enhance Cell Therapy Tech 

06 Nov 2025

US$ 20.00

Qiming Venture Partners has led the over Rmb100 m (US$14 m) angel financing round of IVACTA Biotechnology ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly ending 22 May 2026...

Once largely discreet and illusive in the private capital markets outside of their domains, they are now among the ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.